Lin-Rui Gao (Linrui Gao)

ORCID

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 13

Top Venues

Future oncology (London, England)

Leukemia

Leukemia & lymphoma

Chronic diseases and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Lin-Rui Gao, Xin Li, Xinyue Wang, Yuanzheng Liang, Yunpeng Wu, Xiao-Li Feng, Wei Rao, Xin Liu, Yong-Wen Song, Hui Fang, Bo Chen, Jing Jin, Yue-Ping Liu, Hao Jing, Yuan Tang, Ning-Ning Lu, Shu-Lian Wang, Ye-Xiong Li, Liang Wang, Shu-Nan Qi
Treatment and survival for patients with localized primary ocular adnexal extranodal marginal zone lymphoma. Leukemia 38 (4) (2024)
Lin-Rui Gao, Xinyue Wang, Yunpeng Wu, Xiao-Li Feng, Wei Rao, Xin Liu, Yong-Wen Song, Hui Fang, Bo Chen, Jing Jin, Yue-Ping Liu, Hao Jing, Yuan Tang, Ning-Ning Lu, Ning Li, Wen-Wen Zhang, Yirui Zhai, Shu-Lian Wang, Shu-Nan Qi, Ye-Xiong Li
Treatment outcome, toxicity, and quality of life of patients with bronchus-associated lymphoid tissue lymphoma. Leukemia & lymphoma 65 (6) (2024)
Lin-Rui Gao, Xinyue Wang, Changfa Xia, Yong-Wen Song, Liang Wang, Xin Li, Yong Yang, Jian-Zhong Cao, Ke Chen, Qiu-Zi Zhong, Yuyan Gao, Sheng-Yu Zhou, Xiao-Li Feng, Xiaojun Wang, Ye-Xiong Li, Shu-Nan Qi
Multicenter phase II study of moderate low-dose radiotherapy in indolent non-Hodgkin lymphoma: CLCG-iNHL-01 protocol. Future oncology (London, England) 20 (2) (2024)
Lin-Rui Gao, Xinyue Wang, Yunpeng Wu, Xiao-Li Feng, Wei Rao, Xin Liu, Yong-Wen Song, Hui Fang, Bo Chen, Jing Jin, Yue-Ping Liu, Hao Jing, Yuan Tang, Ning-Ning Lu, Ning Li, Wen-Wen Zhang, Yirui Zhai, Shu-Lian Wang, Shu-Nan Qi, Ye-Xiong Li
Treatment outcome, toxicity, and quality of life of patients with bronchus-associated lymphoid tissue lymphoma. Leukemia & lymphoma (2024)
Lin-Rui Gao, Xin Li, Xinyue Wang, Yuanzheng Liang, Yunpeng Wu, Xiao-Li Feng, Wei Rao, Xin Liu, Yong-Wen Song, Hui Fang, Bo Chen, Jing Jin, Yue-Ping Liu, Hao Jing, Yuan Tang, Ning-Ning Lu, Shu-Lian Wang, Ye-Xiong Li, Liang Wang, Shu-Nan Qi
Treatment and survival for patients with localized primary ocular adnexal extranodal marginal zone lymphoma. Leukemia (2024)
Lin-Rui Gao, Ran Wei, Shirui Qin, Yuan Tian, Wenlong Xia, Yongwen Song, Shulian Wang, Hui Fang, Yu Tang, Hao Jing, Yueping Liu, Yuan Tang, Shunan Qi, Bo Chen, Yexiong Li, Nianzeng Xing, Ningning Lu
Adaptive ultra-hypofractionated whole-pelvic radiotherapy in high-risk and very high-risk prostate cancer on 1.5-Tesla MR-Linac: Estimated delivered dose and early toxicity results. Chronic diseases and translational medicine 10 (1) (2024)
Lin-Rui Gao, Xinyue Wang, Changfa Xia, Yong-Wen Song, Liang Wang, Xin Li, Yong Yang, Jian-Zhong Cao, Ke Chen, Qiu-Zi Zhong, Yuyan Gao, Sheng-Yu Zhou, Xiao-Li Feng, Xiaojun Wang, Ye-Xiong Li, Shu-Nan Qi
Multicenter phase II study of moderate low-dose radiotherapy in indolent non-Hodgkin lymphoma: CLCG-iNHL-01 protocol. Future oncology (London, England) 20 (2) (2024)
Lin-Rui Gao, Ran Wei, Shirui Qin, Yuan Tian, Wenlong Xia, Yongwen Song, Shulian Wang, Hui Fang, Yu Tang, Hao Jing, Yueping Liu, Yuan Tang, Shunan Qi, Bo Chen, Yexiong Li, Nianzeng Xing, Ningning Lu
Adaptive ultra-hypofractionated whole-pelvic radiotherapy in high-risk and very high-risk prostate cancer on 1.5-Tesla MR-Linac: Estimated delivered dose and early toxicity results. Chronic diseases and translational medicine 10 (1) (2024)
Lin-Rui Gao, Xinyue Wang, Changfa Xia, Yong-Wen Song, Liang Wang, Xin Li, Yong Yang, Jian-Zhong Cao, Ke Chen, Qiu-Zi Zhong, Yuyan Gao, Sheng-Yu Zhou, Xiao-Li Feng, Xiaojun Wang, Ye-Xiong Li, Shu-Nan Qi
Multicenter phase II study of moderate low-dose radiotherapy in indolent non-Hodgkin lymphoma: CLCG-iNHL-01 protocol. Future oncology (London, England) 20 (2) (2024)
Lin-Rui Gao, Xinyue Wang, Yunpeng Wu, Xiao-Li Feng, Wei Rao, Xin Liu, Yong-Wen Song, Hui Fang, Bo Chen, Jing Jin, Yue-Ping Liu, Hao Jing, Yuan Tang, Ning-Ning Lu, Ning Li, Wen-Wen Zhang, Yirui Zhai, Shu-Lian Wang, Shu-Nan Qi, Ye-Xiong Li
Treatment outcome, toxicity, and quality of life of patients with bronchus-associated lymphoid tissue lymphoma. Leukemia & lymphoma 65 (6) (2024)
Lin-Rui Gao, Xin Li, Xinyue Wang, Yuanzheng Liang, Yunpeng Wu, Xiao-Li Feng, Wei Rao, Xin Liu, Yong-Wen Song, Hui Fang, Bo Chen, Jing Jin, Yue-Ping Liu, Hao Jing, Yuan Tang, Ning-Ning Lu, Shu-Lian Wang, Ye-Xiong Li, Liang Wang, Shu-Nan Qi
Treatment and survival for patients with localized primary ocular adnexal extranodal marginal zone lymphoma. Leukemia 38 (4) (2024)
Lin-Rui Gao, Xin Li, Xinyue Wang, Yuanzheng Liang, Yunpeng Wu, Xiao-Li Feng, Wei Rao, Xin Liu, Yong-Wen Song, Hui Fang, Bo Chen, Jing Jin, Yue-Ping Liu, Hao Jing, Yuan Tang, Ning-Ning Lu, Shu-Lian Wang, Ye-Xiong Li, Liang Wang, Shu-Nan Qi
Treatment and survival for patients with localized primary ocular adnexal extranodal marginal zone lymphoma. Leukemia 38 (4) (2024)
Lin-Rui Gao, Xinyue Wang, Changfa Xia, Yong-Wen Song, Liang Wang, Xin Li, Yong Yang, Jian-Zhong Cao, Ke Chen, Qiu-Zi Zhong, Yuyan Gao, Sheng-Yu Zhou, Xiao-Li Feng, Xiaojun Wang, Ye-Xiong Li, Shu-Nan Qi
Multicenter phase II study of moderate low-dose radiotherapy in indolent non-Hodgkin lymphoma: CLCG-iNHL-01 protocol. Future oncology (London, England) (2024)

Lin-Rui Gao.css-eqlu8i{font-size:small;padding-left:4px;} (Linrui Gao)

Publication Activity (10 Years)

Top Topics

Top Venues

Lin-Rui Gao (Linrui Gao)